Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multimodal Evaluation of Cryotherapy to Reduce Incidence of Chemotherapy-induced Peripheral Neurotoxicity in Breast Cancer Patients Treated With Paclitaxel Weekly

NCT07780955 is registered in ClinicalTrials.gov with Azienda Sanitaria dell'Alto Adige as lead sponsor.

NCT NCT07780955
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07780955 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multimodal Evaluation of Cryotherapy to Reduce Incidence of Chemotherapy-induced Peripheral Neurotoxicity in Breast Cancer Patients Treated With Paclitaxel Weekly
Lead sponsor
Azienda Sanitaria dell'Alto Adige
Phase
Not applicable
Overall status
Recruiting
Start date
October 11, 2025
Completion date
October 31, 2028
Enrollment
144 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy induced peripheral neuropathy, chemotherapy induced peripheral neuropathy (cipn), cipn, cipn - chemotherapy-induced peripheral neuropathy, cipn in adjuvant breast cancer patients